|
SGK269 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.396800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.281500E-03 |
| Normal-vs-Stage2 |
2.615400E-01 |
| Normal-vs-Stage3 |
7.084300E-02 |
| Normal-vs-Stage4 |
1.138210E-01 |
| Stage1-vs-Stage2 |
6.885000E-01 |
| Stage1-vs-Stage3 |
7.446400E-01 |
| Stage1-vs-Stage4 |
8.666000E-01 |
| Stage2-vs-Stage3 |
8.854200E-01 |
| Stage2-vs-Stage4 |
8.512600E-01 |
| Stage3-vs-Stage4 |
9.410200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.978200E-03 |
| Normal-vs-AfricanAmerican |
4.338500E-02 |
| Normal-vs-Asian |
1.115380E-01 |
| Caucasian-vs-AfricanAmerican |
2.353000E-01 |
| Caucasian-vs-Asian |
9.121000E-01 |
| AfricanAmerican-vs-Asian |
3.193400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.321800E-02 |
| Normal-vs-Female |
1.048390E-02 |
| Male-vs-Female |
9.809400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.201000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.020300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.245800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.961800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.088800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.366400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.204800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.972400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.060600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.572200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.781400E-01 |
| Classical-VS-Follicular |
3.0351000002149E-07 |
| Classical-VS-Other |
3.564800E-01 |
| Classical-VS-Normal |
5.52059999999743E-05 |
| Tall-VS-Follicular |
3.831500E-02 |
| Tall-VS-Other |
7.092000E-01 |
| Tall-VS-Normal |
2.058400E-01 |
| Follicular-VS-Other |
4.519000E-01 |
| Follicular-VS-Normal |
1.735590E-01 |
| Other-VS-Normal |
8.182200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.517800E-01 |
| Normal-vs-N1 |
1.233840E-01 |
| N0-vs-N1 |
4.650400E-01 |
|
|
